Assessment of National Coverage and Out-of-Pocket Costs for Sacubitril/Valsartan Under Medicare Part D.

DeJong, Colette, Dhruv S Kazi, Adams Dudley, Randi Chen, and Chien-Wen Tseng. 2019. “Assessment of National Coverage and Out-of-Pocket Costs for Sacubitril/Valsartan Under Medicare Part D.”. JAMA Cardiology 4 (8): 828-30.

Abstract

This study examines the insurance coverage and out-of-pocket costs to Medicare beneficiaries for the angiotensin receptor–neprilysin inhibitor sacubitril/valsartan.

Last updated on 09/26/2024
PubMed